KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Intangibles (2017 - 2025)

Historic Change in Intangibles for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $7.4 million.

  • Amneal Pharmaceuticals' Change in Intangibles rose 10594.44% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 6137.26%. This contributed to the annual value of $14.6 million for FY2024, which is 3456.32% down from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Change in Intangibles is $7.4 million, which was up 10594.44% from $900000.0 recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Change in Intangibles ranged from a high of $31.8 million in Q3 2022 and a low of $338000.0 during Q1 2023
  • Moreover, its 5-year median value for Change in Intangibles was $1.2 million (2021), whereas its average is $6.2 million.
  • Within the past 5 years, the most significant YoY rise in Amneal Pharmaceuticals' Change in Intangibles was 276982.25% (2024), while the steepest drop was 9698.49% (2024).
  • Over the past 5 years, Amneal Pharmaceuticals' Change in Intangibles (Quarter) stood at $1.2 million in 2021, then surged by 2550.0% to $31.8 million in 2022, then tumbled by 37.42% to $19.9 million in 2023, then tumbled by 96.98% to $600000.0 in 2024, then skyrocketed by 1135.67% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $900000.0 for Q2 2025, and $4.2 million during Q1 2025.